These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22473661)

  • 1. Organogold(III) supramolecular polymers for anticancer treatment.
    Zhang JJ; Lu W; Sun RW; Che CM
    Angew Chem Int Ed Engl; 2012 May; 51(20):4882-6. PubMed ID: 22473661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
    Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
    Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: solution behavior, reactions with model proteins, antiproliferative properties.
    Maiore L; Cinellu MA; Nobili S; Landini I; Mini E; Gabbiani C; Messori L
    J Inorg Biochem; 2012 Mar; 108():123-7. PubMed ID: 22173093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cytotoxicity of selected organogold(III) compounds.
    Coronnello M; Mini E; Caciagli B; Cinellu MA; Bindoli A; Gabbiani C; Messori L
    J Med Chem; 2005 Oct; 48(21):6761-5. PubMed ID: 16220992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic studies on two dinuclear organogold(III) compounds showing appreciable antiproliferative properties and a high redox stability.
    Gabbiani C; Casini A; Kelter G; Cocco F; Cinellu MA; Fiebig HH; Messori L
    Metallomics; 2011 Dec; 3(12):1318-23. PubMed ID: 21887452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cytotoxic and cytostatic gold(III) corrole.
    Teo RD; Gray HB; Lim P; Termini J; Domeshek E; Gross Z
    Chem Commun (Camb); 2014 Nov; 50(89):13789-92. PubMed ID: 25252099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
    Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
    Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
    Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
    Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
    Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
    J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer effect and mechanism of a Se-modified porphyrin Au(III) complex.
    Yang FR; Li Y; Zhang XH; Wang M; Guo HR; Ruan WJ
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3592-6. PubMed ID: 26152428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical fluoroquinolone gold(III) chelates as potential anticancer agents: relevance of DNA and protein interactions for their mechanism of action.
    Gouvea LR; Garcia LS; Lachter DR; Nunes PR; de Castro Pereira F; Silveira-Lacerda EP; Louro SR; Barbeira PJ; Teixeira LR
    Eur J Med Chem; 2012 Sep; 55():67-73. PubMed ID: 22835721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.
    Serratrice M; Cinellu MA; Maiore L; Pilo M; Zucca A; Gabbiani C; Guerri A; Landini I; Nobili S; Mini E; Messori L
    Inorg Chem; 2012 Mar; 51(5):3161-71. PubMed ID: 22339487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancer chemotherapy.
    Kouodom MN; Boscutti G; Celegato M; Crisma M; Sitran S; Aldinucci D; Formaggio F; Ronconi L; Fregona D
    J Inorg Biochem; 2012 Dec; 117():248-60. PubMed ID: 22877925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
    Ronconi L; Marzano C; Zanello P; Corsini M; Miolo G; Maccà C; Trevisan A; Fregona D
    J Med Chem; 2006 Mar; 49(5):1648-57. PubMed ID: 16509581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of Gold(I) Complexes Containing Cinnamide: In Vitro Evaluation of Anticancer Activity in 2D and 3D Spheroidal Models of Melanoma and In Vivo Angiogenesis.
    Ganga Reddy V; Srinivasa Reddy T; Privér SH; Bai Y; Mishra S; Wlodkowic D; Mirzadeh N; Bhargava S
    Inorg Chem; 2019 May; 58(9):5988-5999. PubMed ID: 30985125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deubiquitinases as potential anti-cancer targets for gold(III) complexes.
    Zhang JJ; Ng KM; Lok CN; Sun RW; Che CM
    Chem Commun (Camb); 2013 Jun; 49(45):5153-5. PubMed ID: 23629480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
    Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
    Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles.
    Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L
    Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of polymeric gold glyco-conjugates as anti-cancer agents.
    Ahmed M; Mamba S; Yang XH; Darkwa J; Kumar P; Narain R
    Bioconjug Chem; 2013 Jun; 24(6):979-86. PubMed ID: 23631753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
    Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
    Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.